Interestingly, VEGFR-2 blockade predominantly upregulated PD-L1 expression in HCC cells and increased the PD-1 expression in tumor-infiltrating CD4+ T cells via interferon-gamma of the endothelial cells paracrine. The gene discussed is KDR; the disease is hepatocellular carcinoma.